Related Experiment Videos
Effect of a collaborative intervention by pharmacists and dentists on smoking cessation
Sanah Hasan1, Hamzah Alzubaidi2, Raghad Hashim3
1Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates; Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Purpose:
To evaluate the effectiveness of a structured interprofessional smoking cessation intervention delivered by pharmacists and dentists.
Methods:
A single-arm quasi-experimental, pre-post interventional study was conducted among adult smokers attending a university dental clinic. The program combined behavioral counseling (WHO 5A's and motivational interviewing), optional Nicotine Replacement Therapy (NRT), dental reinforcement, and digital follow-up via WhatsApp. Participants were followed at 3 and 6 months. Outcomes included smoking cessation or reduction, nicotine dependence (Fagerström Test), and biochemical verification using exhaled carbon monoxide (CO) and salivary cotinine (COT). Statistical analyses included chi-square, paired t-tests, Wilcoxon signed-rank and Mann-Whitney U tests with effect size = r; significance was set at p < 0.05.
Results:
One-hundred-forty participants enrolled in the program. At 3 months, 34 participants achieved abstinence and 21 reduced smoking; at 6 months, 30 achieved abstinence and 28 reduced smoking. Mean CO levels decreased significantly from 17.42 ± 10.90 ppm to 13.56 ± 12.21 ppm at 6 months (p < 0.001; r = 0.58). Nicotine dependence scores declined from 4.91 ± 2.69 to 4.16 ± 2.99 at 6 months (p = 0.042; r = 0.27). Among reducers, daily cigarette consumption decreased by over 50% at both follow-ups (p < 0.001; r = 0.88). At 6 months, cessation and reduction rates were significantly higher with counseling + NRT compared to counseling alone (p = 0.019; r = 0.31).
Conclusion:
This program utilizing complementary interprofessional roles of pharmacists and dentists was associated with improvements in smoking cessation outcomes, particularly when combining behavioral and pharmacological approaches. This model offered a plausible strategy to overcome individual professional barriers to enhance tobacco cessation, and supported integrating pharmacists into non-traditional clinical settings.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Combined Effects of Drugs: Synergism
Such synergistic combinations...
COPD: Management Using Bronchodilators and Corticosteroids
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment